scispace - formally typeset
T

Tracy Hussell

Researcher at University of Manchester

Publications -  178
Citations -  13439

Tracy Hussell is an academic researcher from University of Manchester. The author has contributed to research in topics: Immune system & Inflammation. The author has an hindex of 53, co-authored 155 publications receiving 11502 citations. Previous affiliations of Tracy Hussell include Manchester Academic Health Science Centre & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Alveolar macrophages: plasticity in a tissue-specific context

TL;DR: The unique tissue location and function of alveolarmacrophages distinguish them from other macrophage populations and suggest that it is important to classify macrophages according to the site that they occupy.
Journal ArticleDOI

IRF5 Promotes Inflammatory Macrophage Polarization and TH1-TH17 Responses

TL;DR: Global gene expression analysis demonstrated that exogenous IRF5 upregulated or downregulated expression of established phenotypic markers of M1 or M2 macrophages, respectively, suggesting a critical role for IRf5 in M1 macrophage polarization and defining a previously unknown function forIRF5 as a transcriptional repressor.
Journal Article

Irf5 promotes inflammatory macrophage polarization and th1/th17 response

TL;DR: The authors showed that IRF5 expression in macrophages was reversibly induced by inflammatory stimuli and contributed to the plasticity of macrophage polarization, leading to a potent T helper type 1 (TH1)-TH17 response.
Journal ArticleDOI

The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori

TL;DR: The response of low-grade B-cell gastric MALT lymphomas to stimulating strains of H pylori is dependent on H-pylori-specific T cells and their products, rather than the bacteria themselves.
Journal ArticleDOI

Progress and prospects of early detection in lung cancer

TL;DR: Despite significant developments in the oncological management of late stage lung cancer over recent years, survival remains poor and the UK Office for National Statistics reported that patients diagnosed with distant metastatic disease had a 1-year survival rate of just 15–19% compared with 81–85% for stage I.